ALEC - צמיחת הכנסות שנתית ב-12 החודשים האחרונים alector.com

Supply chain optimization for bioccomponents ensures long-term sustainability for Alector, Inc. (ALEC), although short-term risks of trial failures and loss of funding persist. Current developments in brain immunology confirm growth potential. This 12-month YoY sales growth chart visualizes this trend, where the 150.50 indicator expresses the state of the metric at the company's current stage of development.
Alector Inc. (ALEC) - פילוחי מדדים ודוחות פיננסיים

Alector, Inc. (ALEC) maintains a critical dependence on external CRO and CMO contractors, leaving the business vulnerable to supply chain disruptions and necessitating rigorous control over operational flows. Analyzing LTM sales dynamics year-over-year allows for the removal of one-time factors from revenue, measuring the real growth rate of inflows over the year and helping investors timely identify stagnation or hidden growth potential.